Trial site
Takamatsu Red Cross Hospital
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease4 trials
- Obesity2 trials
- Heart failure1 trial
- Psoriasis1 trial
- Stroke1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting4 trials
- Lead sponsor
- Amgen4 trials
- Janssen Research & Development, LLC3 trials
- Abivax S.A.2 trials
- Bayer1 trial
- Eli Lilly and Company1 trial
- and 4 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026